{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T19:54:28Z","timestamp":1768766068204,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2020R1I1A3A04037773"],"award-info":[{"award-number":["NRF-2020R1I1A3A04037773"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019266","name":"Korea Medical Device Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["RS-2022-00141589"],"award-info":[{"award-number":["RS-2022-00141589"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["1711179419"],"award-info":[{"award-number":["1711179419"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.anndiagpath.2024.152317","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T02:28:55Z","timestamp":1713407335000},"page":"152317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies"],"prefix":"10.1016","volume":"71","author":[{"given":"Seon Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ik-Chan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gye Cheol","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152317_bb0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Campo","year":"2017"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0010","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ajh.26828","article-title":"Atypical chronic myeloid leukemia and myelodysplastic\/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management","volume":"98","author":"Patnaik","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891961","article-title":"Chronic neutrophilic leukemia: a comprehensive review of clinical characteristics, genetic landscape and management","volume":"12","author":"Thomopoulos","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0030","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.932608","article-title":"A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer","volume":"12","author":"Park","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajh.26481","article-title":"Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management","volume":"97","author":"Szuber","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0045","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","article-title":"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41408-018-0058-7","article-title":"CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival","volume":"8","author":"Szuber","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0055","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/ejh.14044","article-title":"Prognostic value of the mutation types and dynamics of FLT3-ITD in acute myeloid leukemia","volume":"111","author":"Koo","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s11899-017-0413-y","article-title":"Recent progress in chronic neutrophilic leukemia and atypical chronic myeloid leukemia","volume":"12","author":"Dao","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.leukres.2005.07.005","article-title":"Young age MDS: differences between Western and Eastern countries","volume":"30","author":"Paydas","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3343\/alm.2017.37.6.465","article-title":"Diagnostics and prognostication of myelodysplastic syndromes","volume":"37","author":"Zini","year":"2017","journal-title":"Ann Lab Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152317_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/cancers13030481","article-title":"Asian population is more prone to develop high-risk myelodysplastic syndrome, concordantly with their propensity to exhibit high-risk cytogenetic aberrations","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.leu.2402798","article-title":"Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome","volume":"17","author":"Lee","year":"2003","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152317_bb0085","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/bloodadvances.2022008204","article-title":"Chronic neutrophilic leukemia and aCML should be considered a single entity based on molecular profiles and outcomes","volume":"7","author":"Carreno-Tarragona","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/blood.2020009680","article-title":"CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome","volume":"139","author":"Taube","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00277-023-05106-8","article-title":"Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia","volume":"102","author":"Sun","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ajh.24722","article-title":"Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia","volume":"92","author":"Patnaik","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0105","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1002\/cncr.31586","article-title":"CSF3R mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia","volume":"124","author":"Zhang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0110","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1182\/blood-2016-04-709899","article-title":"CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML","volume":"127","author":"Maxson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0115","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.2019004179","article-title":"Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia","volume":"135","author":"Tarlock","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0120","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.3324\/haematol.2018.189043","article-title":"Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA","volume":"103","author":"Tien","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2024.152317_bb0125","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1200\/JCO.19.00895","article-title":"Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia","volume":"38","author":"Dao","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T06:55:35Z","timestamp":1718088935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":25,"alternative-id":["S1092913424000546"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152317","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152317"}}